{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T06:39:50Z","timestamp":1791614390062,"version":"4.3.4"},"reference-count":85,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2024,9,24]],"date-time":"2024-09-24T00:00:00Z","timestamp":1727136000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,9,24]],"date-time":"2024-09-24T00:00:00Z","timestamp":1727136000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Hum Genet"],"published-print":{"date-parts":[[2024,11]]},"DOI":"10.1038\/s41431-024-01688-7","type":"journal-article","created":{"date-parts":[[2024,9,24]],"date-time":"2024-09-24T12:49:56Z","timestamp":1727182196000},"page":"1361-1370","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Predicting age of onset and progression of disease in late-onset genetic neurodegenerative diseases: An ethics review and research agenda"],"prefix":"10.1038","volume":"32","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4799-8587","authenticated-orcid":false,"given":"Max","family":"Rensink","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ineke","family":"Bolt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maartje","family":"Schermer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,9,24]]},"reference":[{"key":"1688_CR1","doi-asserted-by":"publisher","first-page":"1396","DOI":"10.1038\/ejhg.2016.36","volume":"24","author":"SS Baig","year":"2016","unstructured":"Baig SS, Strong M, Rosser E, Taverner NV, Glew R, Miedzybrodzka Z, et al. 22 Years of predictive testing for Huntington\u2019s disease: the experience of the UK Huntington\u2019s Prediction Consortium. Eur J Hum Genet. 2016;24:1396\u2013402.","journal-title":"Eur J Hum Genet"},{"key":"1688_CR2","unstructured":"Caron NS, Wright GEB, Hayden MR Huntington disease. GeneReviews\u00ae[Internet]. (1998). [Last Update: June 11, 2020]."},{"key":"1688_CR3","doi-asserted-by":"publisher","first-page":"830","DOI":"10.1136\/medethics-2018-104772","volume":"44","author":"EM Bunnik","year":"2018","unstructured":"Bunnik EM, Richard E, Milne R, Schermer MHN. On the personal utility of Alzheimer\u2019s disease-related biomarker testing in the research context. J Med Ethics. 2018;44:830\u20134.","journal-title":"J Med Ethics"},{"key":"1688_CR4","unstructured":"CureQ. CureQ: Predict, Delay & Cure polyglutamine(Q) caused neurodegeneration 2022. Accessed on 25-06-2024. https:\/\/cureq.nl\/cureq-en\/."},{"key":"1688_CR5","unstructured":"UpToDate. Autosomal dominant spinocerebellar ataxias. In: Helen V Firth AFE, editor. UpToDate. Accessed on 09-08-2024. https:\/\/www.uptodate.com\/contents\/autosomal-dominant-spinocerebellar-ataxias (2024)."},{"key":"1688_CR6","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-020-68301-x","volume":"10","author":"JH Won","year":"2020","unstructured":"Won JH, Kim M, Youn J, Park H. Prediction of age at onset in Parkinson\u2019s disease using objective specific neuroimaging genetics based on a sparse canonical correlation analysis. Sci Rep. 2020;10:11662.","journal-title":"Sci Rep"},{"key":"1688_CR7","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1007\/s12687-018-0371-7","volume":"10","author":"AJ Clarke","year":"2019","unstructured":"Clarke AJ, Wallgren-Pettersson C. Ethics in genetic counselling. J Community Genet. 2019;10:3\u201333.","journal-title":"J Community Genet"},{"key":"1688_CR8","doi-asserted-by":"crossref","unstructured":"Sampaio C. Huntington disease\u2013Update on ongoing therapeutic developments and a look toward the future. Parkinsonism Relat Disord. 2024;122:106049.","DOI":"10.1016\/j.parkreldis.2024.106049"},{"key":"1688_CR9","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12910-020-00524-z","volume":"21","author":"KR Jongsma","year":"2020","unstructured":"Jongsma KR, Bredenoord AL. Ethics parallel research: an approach for (early) ethical guidance of biomedical innovation. BMC Med Ethics. 2020;21:1\u20139.","journal-title":"BMC Med Ethics"},{"key":"1688_CR10","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1111\/bioe.12149","volume":"29","author":"R McDougall","year":"2015","unstructured":"McDougall R. Reviewing literature in bioethics research: Increasing rigour in non\u2010systematic reviews. Bioethics. 2015;29:523\u20138.","journal-title":"Bioethics"},{"key":"1688_CR11","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12910-020-00477-3","volume":"21","author":"JH Williams","year":"2020","unstructured":"Williams JH, Dawson A. Prioritising access to pandemic influenza vaccine: a review of the ethics literature. BMC Med Ethics. 2020;21:1\u20138.","journal-title":"BMC Med Ethics"},{"key":"1688_CR12","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1038\/s41431-018-0255-7","volume":"27","author":"A Bonnard","year":"2019","unstructured":"Bonnard A, Herson A, Gargiulo M, Durr A. Reverse pre-symptomatic testing for Huntington disease: double disclosure when 25% at-risk children reveal the genetic status to their parent. Eur J Hum Genet. 2019;27:22\u20137.","journal-title":"Eur J Hum Genet"},{"key":"1688_CR13","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1136\/jme.18.2.79","volume":"18","author":"G Terrenoire","year":"1992","unstructured":"Terrenoire G. Huntington\u2019s disease and the ethics of genetic prediction. J Med Ethics. 1992;18:79\u201385.","journal-title":"J Med Ethics"},{"key":"1688_CR14","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1002\/bdr2.1629","volume":"112","author":"L Cohen","year":"2020","unstructured":"Cohen L. The de\u2010coders: A historical perspective of the genetic counseling profession. Birth Defects Res. 2020;112:307\u201315.","journal-title":"Birth Defects Res"},{"key":"1688_CR15","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1038\/sj.ejhg.5201983","volume":"16","author":"E Rantanen","year":"2008","unstructured":"Rantanen E, Hietala M, Kristoffersson U, Nippert I, Schmidtke J, Sequeiros J, et al. What is ideal genetic counselling? A survey of current international guidelines. Eur J Hum Genet. 2008;16:445\u201352.","journal-title":"Eur J Hum Genet"},{"key":"1688_CR16","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1007\/s11019-022-10085-0","volume":"25","author":"W Cha\u0144ska","year":"2022","unstructured":"Cha\u0144ska W. The principle of nondirectiveness in genetic counseling. Different meanings and various postulates of normative nature. Med Health Care Philos. 2022;25:383\u201393.","journal-title":"Med Health Care Philos"},{"key":"1688_CR17","doi-asserted-by":"publisher","first-page":"718","DOI":"10.1002\/jgc4.1207","volume":"29","author":"L Jamal","year":"2020","unstructured":"Jamal L, Schupmann W, Berkman BE. An ethical framework for genetic counseling in the genomic era. J Genet Counsel. 2020;29:718\u201327.","journal-title":"J Genet Counsel"},{"key":"1688_CR18","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1111\/j.1399-0004.2012.01900.x","volume":"83","author":"R MacLeod","year":"2013","unstructured":"MacLeod R, Tibben A, Frontali M, Jones A, Martinez\u2010Descales A, Roos RA, et al. Recommendations for the predictive genetic test in Huntington\u2019s disease. Clin Genet. 2013;83:221\u201331.","journal-title":"Clin Genet"},{"key":"1688_CR19","doi-asserted-by":"publisher","first-page":"2038","DOI":"10.1038\/s41436-021-01248-0","volume":"23","author":"A Phillips","year":"2021","unstructured":"Phillips A, Borry P, Van Hoyweghen I, Vears DF. Disclosure of genetic information to family members: A systematic review of normative documents. Genet Med. 2021;23:2038\u201346.","journal-title":"Genet Med"},{"key":"1688_CR20","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1080\/14636778.2021.2007065","volume":"41","author":"DR Gordon","year":"2022","unstructured":"Gordon DR, Koenig BA. \u201cIf relatives inherited the gene, they should inherit the data.\u201d Bringing the family into the room where bioethics happens. N. Genet Soc. 2022;41:23\u201346.","journal-title":"N. Genet Soc"},{"key":"1688_CR21","unstructured":"Royal College of Physicians, Royal College of Pathologists and British Society for Genetic Medicine. Consent and Confidentiality in Genomic Medicine: Guidance on the Use of Genetic and Genomic Information in the Clinic. A report of the Joint Committee on Genomics in Medicine. (2019)."},{"key":"1688_CR22","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1007\/s10897-016-0018-y","volume":"26","author":"A Fenwick","year":"2017","unstructured":"Fenwick A, Plantinga M, Dheensa S, Lucassen A. Predictive genetic testing of children for adult-onset conditions: negotiating requests with parents. J Genet Counsel. 2017;26:244\u201350.","journal-title":"J Genet Counsel"},{"key":"1688_CR23","doi-asserted-by":"publisher","first-page":"2190","DOI":"10.1038\/s41436-019-0483-4","volume":"21","author":"JR Garrett","year":"2019","unstructured":"Garrett JR, Lantos JD, Biesecker LG, Childerhose JE, Chung WK, Holm IA, et al. Rethinking the \u201copen future\u201d argument against predictive genetic testing of children. Genet Med. 2019;21:2190\u20138.","journal-title":"Genet Med"},{"key":"1688_CR24","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1136\/jmg.31.10.785","volume":"31","author":"A Clarke","year":"1994","unstructured":"Clarke A. The genetic testing of children. Working Party of the Clinical Genetics Society (UK). J Med Genet. 1994;31:785.","journal-title":"J Med Genet"},{"key":"1688_CR25","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1038\/gim.2015.181","volume":"18","author":"CE Wakefield","year":"2016","unstructured":"Wakefield CE, Hanlon LV, Tucker KM, Patenaude AF, Signorelli C, McLoone JK, et al. The psychological impact of genetic information on children: a systematic review. Genet Med. 2016;18:755\u201362.","journal-title":"Genet Med"},{"key":"1688_CR26","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1136\/medethics-2011-100055","volume":"38","author":"C Mand","year":"2012","unstructured":"Mand C, Gillam L, Delatycki MB, Duncan RE. Predictive genetic testing in minors for late-onset conditions: a chronological and analytical review of the ethical arguments. J Med Ethics. 2012;38:519\u201324.","journal-title":"J Med Ethics"},{"key":"1688_CR27","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1016\/j.ajhg.2015.05.022","volume":"97","author":"JR Botkin","year":"2015","unstructured":"Botkin JR, Belmont JW, Berg JS, Berkman BE, Bombard Y, Holm IA, et al. Points to Consider: Ethical, Legal, And Psychosocial Implications Of Genetic Testing In Children And Adolescents. Am J Hum Genet. 2015;97:6\u201321.","journal-title":"Am J Hum Genet"},{"key":"1688_CR28","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1093\/humupd\/dms058","volume":"19","author":"CEM de Die-Smulders","year":"2013","unstructured":"de Die-Smulders CEM, De Wert G, Liebaers I, Tibben A, Evers-Kiebooms G. Reproductive options for prospective parents in families with Huntington\u2019s disease: clinical, psychological and ethical reflections. Hum Reprod Update. 2013;19:304\u201315.","journal-title":"Hum Reprod Update"},{"key":"1688_CR29","doi-asserted-by":"publisher","first-page":"1","DOI":"10.21926\/obm.neurobiol.2101085","volume":"5","author":"J Geraedts","year":"2021","unstructured":"Geraedts J. Prenatal and preimplantation genetic diagnosis of Huntington\u2019s disease. OBM Neurobiol. 2021;5:1\u201311.","journal-title":"OBM Neurobiol"},{"key":"1688_CR30","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1038\/sj.ejhg.5201598","volume":"14","author":"S Soini","year":"2006","unstructured":"Soini S, Ibarreta D, Anastasiadou V, Aym\u00e9 S, Braga S, Cornel M, et al. The interface between assisted reproductive technologies and genetics: technical, social, ethical and legal issues. Eur J Hum Genet. 2006;14:588\u2013645.","journal-title":"Eur J Hum Genet"},{"key":"1688_CR31","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1163\/15718093-12420347","volume":"24","author":"A-M Duguet","year":"2017","unstructured":"Duguet A-M, Boyer-Beviere B. Preimplantation genetic diagnosis: the situation in France and in other European countries. Eur J Health Law. 2017;24:160\u201374.","journal-title":"Eur J Health Law"},{"key":"1688_CR32","doi-asserted-by":"publisher","first-page":"1081","DOI":"10.1002\/ajmg.b.31079","volume":"153","author":"C Erwin","year":"2010","unstructured":"Erwin C, Williams JK, Juhl AR, Mengeling M, Mills JA, Bombard Y, et al. Perception, experience, and response to genetic discrimination in Huntington disease: The international RESPOND\u2010HD study. Am J Med Genet Part B: Neuropsychiatr Genet. 2010;153:1081\u201393.","journal-title":"Am J Med Genet Part B: Neuropsychiatr Genet"},{"key":"1688_CR33","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1179\/hrge.11.2.e35336gt18776032","volume":"11","author":"A Lilani","year":"2005","unstructured":"Lilani A. Ethical issues and policy analysis for genetic testing: Huntington\u2019s disease as a paradigm for diseases with a late onset. Hum Reprod Genet Ethics. 2005;11:28\u201334.","journal-title":"Hum Reprod Genet Ethics"},{"key":"1688_CR34","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1038\/jhg.2015.151","volume":"61","author":"A Wauters","year":"2016","unstructured":"Wauters A, Van Hoyweghen I. Global trends on fears and concerns of genetic discrimination: a systematic literature review. J Hum Genet. 2016;61:275\u201382.","journal-title":"J Hum Genet"},{"key":"1688_CR35","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1163\/15718093-12453366","volume":"24","author":"A De Paor","year":"2017","unstructured":"De Paor A. Genetic discrimination: a case for a European legislative response? Eur J Health Law. 2017;24:135\u201359.","journal-title":"Eur J Health Law"},{"key":"1688_CR36","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1007\/s12687-012-0078-0","volume":"3","author":"S Soini","year":"2012","unstructured":"Soini S. Genetic testing legislation in Western Europe-a fluctuating regulatory target. J Community Genet. 2012;3:143\u201353.","journal-title":"J Community Genet"},{"key":"1688_CR37","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1038\/s41588-020-0606-5","volume":"52","author":"Y Joly","year":"2020","unstructured":"Joly Y, Dalp\u00e9 G, Dupras C, B\u00e9vi\u00e8re-Boyer B, De Paor A, Dove ES, et al. Establishing the International genetic discrimination Observatory. Nat Genet. 2020;52:466\u20138.","journal-title":"Nat Genet"},{"key":"1688_CR38","doi-asserted-by":"publisher","first-page":"1309","DOI":"10.3233\/JAD-180638","volume":"66","author":"M Smedinga","year":"2018","unstructured":"Smedinga M, Tromp K, Schermer MHN, Richard E. Ethical arguments concerning the use of Alzheimer\u2019s disease biomarkers in individuals with no or mild cognitive impairment: a systematic review and framework for discussion. J Alzheimers Dis. 2018;66:1309\u201322.","journal-title":"J Alzheimers Dis"},{"key":"1688_CR39","doi-asserted-by":"publisher","first-page":"5773","DOI":"10.1002\/alz.13410","volume":"19","author":"J van der Schaar","year":"2023","unstructured":"van der Schaar J, Visser LNC, Ket JCF, Groot C, Pijnenburg YAL, Scheltens P, et al. Impact of sharing Alzheimer\u2019s disease biomarkers with individuals without dementia: A systematic review and meta\u2010analysis of empirical data. Alzheimer\u2019s Dement 2023;19:5773\u201394.","journal-title":"Alzheimer\u2019s Dement"},{"key":"1688_CR40","doi-asserted-by":"crossref","unstructured":"Yadollahikhales G, Rojas JC. Anti-amyloid immunotherapies for Alzheimer\u2019s disease: a 2023 clinical update. Neurotherapeutics. 2023;20:914\u201331.","DOI":"10.1007\/s13311-023-01405-0"},{"key":"1688_CR41","doi-asserted-by":"publisher","first-page":"923","DOI":"10.3233\/JAD-191159","volume":"76","author":"Z Angehrn","year":"2020","unstructured":"Angehrn Z, Sostar J, Nordon C, Turner A, Gove D, Karcher H, et al. Ethical and social implications of using predictive modeling for alzheimer\u2019s disease prevention: a systematic literature review. J Alzheimers Dis. 2020;76:923\u201340.","journal-title":"J Alzheimers Dis"},{"key":"1688_CR42","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1186\/s13195-022-00971-3","volume":"14","author":"J van der Schaar","year":"2022","unstructured":"van der Schaar J, Visser LNC, Bouwman FH, Ket JCF, Scheltens P, Bredenoord AL, et al. Considerations regarding a diagnosis of Alzheimer\u2019s disease before dementia: a systematic review. Alzheimers Res Ther. 2022;14:31.","journal-title":"Alzheimers Res Ther"},{"key":"1688_CR43","first-page":"9.15. 1","volume":"81","author":"W Burke","year":"2014","unstructured":"Burke W. Genetic tests: clinical validity and clinical utility. Curr Protoc Hum Genet. 2014;81:9.15. 1\u20139. 8.","journal-title":"Curr Protoc Hum Genet"},{"key":"1688_CR44","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1136\/medethics-2013-101887","volume":"41","author":"EM Bunnik","year":"2015","unstructured":"Bunnik EM, Janssens AC, Schermer MH. Personal utility in genomic testing: is there such a thing? J Med Ethics. 2015;41:322\u20136.","journal-title":"J Med Ethics"},{"key":"1688_CR45","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1002\/eahr.500146","volume":"44","author":"EM Bunnik","year":"2022","unstructured":"Bunnik EM, Smedinga M, Milne R, Georges J, Richard E, Schermer MHN. Ethical frameworks for disclosure of Alzheimer disease biomarkers to research participants: conflicting norms and a nuanced policy. Ethics Hum Res. 2022;44:2\u201313.","journal-title":"Ethics Hum Res"},{"key":"1688_CR46","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12910-020-00476-4","volume":"21","author":"Z Alpinar-Sencan","year":"2020","unstructured":"Alpinar-Sencan Z, Schicktanz S. Addressing ethical challenges of disclosure in dementia prediction: limitations of current guidelines and suggestions to proceed. BMC Med Ethics. 2020;21:1\u201311.","journal-title":"BMC Med Ethics"},{"key":"1688_CR47","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1038\/gim.2015.117","volume":"18","author":"C Van Cauwenberghe","year":"2016","unstructured":"Van Cauwenberghe C, Van Broeckhoven C, Sleegers K. The genetic landscape of Alzheimer disease: clinical implications and perspectives. Genet Med. 2016;18:421\u201330.","journal-title":"Genet Med"},{"key":"1688_CR48","doi-asserted-by":"publisher","first-page":"a036525","DOI":"10.1101\/cshperspect.a036525","volume":"10","author":"JS Goldman","year":"2020","unstructured":"Goldman JS. Predictive genetic counseling for neurodegenerative diseases: past, present, and future. Cold Spring Harb Perspect Med. 2020;10:a036525.","journal-title":"Cold Spring Harb Perspect Med"},{"key":"1688_CR49","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s10654-016-0123-0","volume":"31","author":"EM Bunnik","year":"2016","unstructured":"Bunnik EM, Vernooij MW. Incidental findings in population imaging revisited. Eur J Epidemiol. 2016;31:1\u20134.","journal-title":"Eur J Epidemiol"},{"key":"1688_CR50","doi-asserted-by":"publisher","first-page":"648","DOI":"10.1111\/bioe.12375","volume":"31","author":"RHP Wouters","year":"2017","unstructured":"Wouters RHP, Cornelis C, Newson AJ, Bunnik EM, Bredenoord AL. Scanning the body, sequencing the genome: Dealing with unsolicited findings. Bioethics. 2017;31:648\u201356.","journal-title":"Bioethics"},{"key":"1688_CR51","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1002\/ajmg.b.32699","volume":"180","author":"A Manrique de Lara","year":"2019","unstructured":"Manrique de Lara A, Soto\u2010G\u00f3mez L, N\u00fa\u00f1ez\u2010Acosta E, Saruwatari\u2010Zavala G, Renter\u00eda ME. Ethical issues in susceptibility genetic testing for late\u2010onset neurodegenerative diseases. Am J Med Genet Part B: Neuropsychiatr Genet. 2019;180:609\u201321.","journal-title":"Am J Med Genet Part B: Neuropsychiatr Genet"},{"key":"1688_CR52","unstructured":"Council for International Organizations of Medical Sciences. International ethical guidelines for health-related research involving humans. CIOMS 2016."},{"key":"1688_CR53","doi-asserted-by":"publisher","DOI":"10.1016\/j.psychres.2019.112732","volume":"284","author":"SA Graham","year":"2020","unstructured":"Graham SA, Lee EE, Jeste DV, Van Patten R, Twamley EW, Nebeker C, et al. Artificial intelligence approaches to predicting and detecting cognitive decline in older adults: A conceptual review. Psychiatry Res. 2020;284:112732.","journal-title":"Psychiatry Res"},{"key":"1688_CR54","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2022.788427","volume":"13","author":"H Fr\u00f6hlich","year":"2022","unstructured":"Fr\u00f6hlich H, Bontridder N, Petrovska-Delacr\u00e9ta D, Glaab E, Kluge F, Yacoubi ME, et al. Leveraging the potential of digital technology for better individualized treatment of Parkinson\u2019s disease. Front Neurol. 2022;13:788427.","journal-title":"Front Neurol"},{"key":"1688_CR55","doi-asserted-by":"publisher","first-page":"440","DOI":"10.3390\/diagnostics11030440","volume":"11","author":"F Ursin","year":"2021","unstructured":"Ursin F, Timmermann C, Steger F. Ethical Implications of Alzheimer\u2019s Disease Prediction in Asymptomatic Individuals through Artificial Intelligence. Diagnostics. 2021;11:440.","journal-title":"Diagnostics"},{"key":"1688_CR56","doi-asserted-by":"publisher","DOI":"10.3389\/fdgth.2022.886615","volume":"4","author":"M Milling","year":"2022","unstructured":"Milling M, Pokorny FB, Bartl-Pokorny KD, Schuller BW. Is speech the new blood? Recent progress in AI-based disease detection from audio in a nutshell. Front Digit Health. 2022;4:886615.","journal-title":"Front Digit Health"},{"key":"1688_CR57","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1136\/medethics-2021-107531","volume":"47","author":"JM Dur\u00e1n","year":"2021","unstructured":"Dur\u00e1n JM, Jongsma KR. Who is afraid of black box algorithms? On the epistemological and ethical basis of trust in medical AI. J Med Ethics. 2021;47:329\u201335.","journal-title":"J Med Ethics"},{"key":"1688_CR58","doi-asserted-by":"publisher","first-page":"1516","DOI":"10.1016\/j.jacr.2019.07.028","volume":"16","author":"JR Geis","year":"2019","unstructured":"Geis JR, Brady AP, Wu CC, Spencer J, Ranschaert E, Jaremko JL, et al. Ethics of artificial intelligence in radiology: Summary of the Joint European and North American Multisociety Statement. J Am Coll Radio. 2019;16:1516\u201321.","journal-title":"J Am Coll Radio"},{"key":"1688_CR59","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1016\/j.tig.2009.09.012","volume":"25","author":"AC Need","year":"2009","unstructured":"Need AC, Goldstein DB. Next generation disparities in human genomics: concerns and remedies. Trends Genet. 2009;25:489\u201394.","journal-title":"Trends Genet"},{"key":"1688_CR60","doi-asserted-by":"publisher","DOI":"10.1016\/j.nbd.2020.104871","volume":"141","author":"JS Roberts","year":"2020","unstructured":"Roberts JS, Patterson AK, Uhlmann WR. Genetic testing for neurodegenerative diseases: ethical and health communication challenges. Neurobiol Dis. 2020;141:104871.","journal-title":"Neurobiol Dis"},{"key":"1688_CR61","doi-asserted-by":"crossref","unstructured":"Ahlgrim NS, Garza K, Hoffman C, Rommelfanger KS Prodromes and preclinical detection of brain diseases: surveying the ethical landscape of predicting brain health. eneuro. 2019;6:ENEURO.0439\u201318.2019.","DOI":"10.1523\/ENEURO.0439-18.2019"},{"key":"1688_CR62","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1007\/s00702-018-1934-9","volume":"126","author":"VS Marshe","year":"2019","unstructured":"Marshe VS, Gorbovskaya I, Kanji S, Kish M, M\u00fcller DJ. Clinical implications of APOE genotyping for late-onset Alzheimer\u2019s disease (LOAD) risk estimation: A review of the literature. J Neural Transm. 2019;126:65\u201385.","journal-title":"J Neural Transm"},{"key":"1688_CR63","doi-asserted-by":"publisher","first-page":"724","DOI":"10.1007\/s00415-020-10162-5","volume":"268","author":"M Smedinga","year":"2021","unstructured":"Smedinga M, Darweesh SKL, Bloem BR, Post B, Richard E. Towards early disease modification of Parkinson\u2019s disease: a review of lessons learned in the Alzheimer field. J Neurol. 2021;268:724\u201333.","journal-title":"J Neurol"},{"key":"1688_CR64","doi-asserted-by":"crossref","unstructured":"Rosen AC. Communicating and Using Dementia Risk Evidence. J Alzheimers Dis. 2022;90:933\u2013441.","DOI":"10.3233\/JAD-220722"},{"key":"1688_CR65","doi-asserted-by":"publisher","first-page":"1057","DOI":"10.1111\/scs.12932","volume":"35","author":"SM Nurmi","year":"2021","unstructured":"Nurmi SM, Halkoaho A, Moilanen J, Remes AM, Solje E. The ethical implications of genetic testing in neurodegenerative diseases: A systematic review. Scand J Caring Sci. 2021;35:1057\u201374.","journal-title":"Scand J Caring Sci"},{"key":"1688_CR66","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13195-021-00840-5","volume":"13","author":"LNC Visser","year":"2021","unstructured":"Visser LNC, Minguillon C, S\u00e1nchez-Benavides G, Abramowicz M, Altomare D, Fauria K, et al. Dementia risk communication. A user manual for Brain Health Services\u2014part 3 of 6. Alzheimers Res Ther. 2021;13:1\u201312.","journal-title":"Alzheimers Res Ther"},{"key":"1688_CR67","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1159\/000368888","volume":"18","author":"AG Besser","year":"2015","unstructured":"Besser AG, Sanderson SC, Roberts JS, Chen CA, Christensen KD, Lautenbach DM, et al. Factors affecting recall of different types of personal genetic information about Alzheimer\u2019s disease risk: the REVEAL study. Public Health Genom. 2015;18:78\u201386.","journal-title":"Public Health Genom"},{"key":"1688_CR68","doi-asserted-by":"publisher","first-page":"1487","DOI":"10.1212\/WNL.0b013e318232ac1a","volume":"77","author":"J Karlawish","year":"2011","unstructured":"Karlawish J. Addressing the ethical, policy, and social challenges of preclinical Alzheimer disease. Neurology. 2011;77:1487\u201393.","journal-title":"Neurology"},{"key":"1688_CR69","first-page":"285","volume":"10","author":"SD Stites","year":"2018","unstructured":"Stites SD, Milne R, Karlawish J. Advances in Alzheimer\u2019s imaging are changing the experience of Alzheimer\u2019s disease. Alzheimer\u2019s & Dementia: Diagnosis. Assess Dis Monit. 2018;10:285\u2013300.","journal-title":"Assess Dis Monit"},{"key":"1688_CR70","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1212\/WNL.0000000000000153","volume":"82","author":"JJ Arias","year":"2014","unstructured":"Arias JJ, Karlawish J. Confidentiality in preclinical Alzheimer disease studies: when research and medical records meet. Neurology. 2014;82:725\u20139.","journal-title":"Neurology"},{"key":"1688_CR71","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1111\/bioe.12516","volume":"33","author":"MHN Schermer","year":"2019","unstructured":"Schermer MHN, Richard E. On the reconceptualization of Alzheimer\u2019s disease. Bioethics. 2019;33:138\u201345.","journal-title":"Bioethics"},{"key":"1688_CR72","doi-asserted-by":"publisher","first-page":"746","DOI":"10.1093\/geront\/gnaa113","volume":"61","author":"M Smedinga","year":"2021","unstructured":"Smedinga M, Bunnik EM, Richard E, Schermer MHN. The Framing of \u201cAlzheimer\u2019s Disease\u201d: Differences between scientific and lay literature and their ethical implications. Gerontologist. 2021;61:746\u201355.","journal-title":"Gerontologist"},{"key":"1688_CR73","doi-asserted-by":"publisher","first-page":"917","DOI":"10.3233\/JAD-200884","volume":"79","author":"K Tromp","year":"2021","unstructured":"Tromp K, Smedinga M, Richard E, Perry M, Schermer MHN. Views on early diagnosis of Alzheimer\u2019s disease among dutch physicians: A qualitative interview study. J Alzheimers Dis. 2021;79:917\u201327.","journal-title":"J Alzheimers Dis"},{"key":"1688_CR74","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1176\/appi.ajp.2013.12121590","volume":"171","author":"TT Lineweaver","year":"2014","unstructured":"Lineweaver TT, Bondi MW, Galasko D, Salmon DP. Effect of knowledge of APOE genotype on subjective and objective memory performance in healthy older adults. Am J Psychiatry. 2014;171:201\u20138.","journal-title":"Am J Psychiatry"},{"key":"1688_CR75","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1002\/jgc4.1497","volume":"31","author":"G Wieringa","year":"2022","unstructured":"Wieringa G, Dale M, Eccles FJR. The experience of a sample of individuals in the United Kingdom living in the pre\u2010manifest stage of Huntington\u2019s disease: An interpretative phenomenological analysis. J Genet Counsel. 2022;31:375\u201387.","journal-title":"J Genet Counsel"},{"key":"1688_CR76","unstructured":"Presidential Commission for the Study of Bioethical Issues. Anticipate and Communicate: Ethical Management of Incidental and Secondary Findings in the Clinical, Research, and Direct-to-Consumer Contexts. Washington (2013)."},{"key":"1688_CR77","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1038\/ejhg.2013.46","volume":"21","author":"CG Van El","year":"2013","unstructured":"Van El CG, Cornel MC, Borry P, Hastings RJ, Fellmann F, Hodgson SV, et al. Whole-genome sequencing in health care. Eur J Hum Genet. 2013;21:580\u20134.","journal-title":"Eur J Hum Genet"},{"key":"1688_CR78","doi-asserted-by":"publisher","first-page":"1488","DOI":"10.1212\/WNL.0000000000001451","volume":"84","author":"SY Kim","year":"2015","unstructured":"Kim SY, Karlawish J, Berkman BE. Ethics of genetic and biomarker test disclosures in neurodegenerative disease prevention trials. Neurology. 2015;84:1488\u201394.","journal-title":"Neurology"},{"key":"1688_CR79","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1111\/j.1399-0004.2006.00692.x","volume":"70","author":"P Borry","year":"2006","unstructured":"Borry P, Stulti\u00ebns L, Nys H, Cassiman JJ, Dierickx K. Presymptomatic and predictive genetic testing in minors: a systematic review of guidelines and position papers. Clin Genet. 2006;70:374\u201381.","journal-title":"Clin Genet"},{"key":"1688_CR80","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1002\/mdc3.13148","volume":"8","author":"M Oosterloo","year":"2021","unstructured":"Oosterloo M, de Greef BTA, Bijlsma EK, Durr A, Tabrizi SJ, Estevez\u2010Fraga C, et al. Disease onset in Huntington's disease: when is the conversion? Mov Disord Clin Pract. 2021;8:352\u201360.","journal-title":"Mov Disord Clin Pract"},{"key":"1688_CR81","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1002\/mds.870110204","volume":"11","author":"K Kieburtz","year":"1996","unstructured":"Kieburtz K, Penney JB, Como P, Ranen N, Feigin A, Abwender D, et al. Unified Huntington's disease rating scale: reliability and consistency. Mov Disord. 1996;11:136\u201342.","journal-title":"Mov Disord"},{"key":"1688_CR82","doi-asserted-by":"publisher","first-page":"1717","DOI":"10.1212\/01.wnl.0000219042.60538.92","volume":"66","author":"T Schmitz-Hubsch","year":"2006","unstructured":"Schmitz-Hubsch T, Du Montcel ST, Baliko L, Berciano J, Boesch S, Depondt C, et al. Scale for the assessment and rating of ataxia: development of a new clinical scale. Neurology 2006;66:1717\u201320.","journal-title":"Neurology"},{"key":"1688_CR83","unstructured":"FDA-NIH Biomarker Working Group. BEST (Biomarkers, EndpointS, and other Tools) Resource [Internet]. 2016 Jan 28 [Updated 2021 Nov 29]."},{"key":"1688_CR84","doi-asserted-by":"publisher","first-page":"632","DOI":"10.1016\/S1474-4422(22)00120-X","volume":"21","author":"SJ Tabrizi","year":"2022","unstructured":"Tabrizi SJ, Schobel S, Gantman EC, Mansbach A, Borowsky B, Konstantinova P, et al. A biological classification of Huntington\u2019s disease: the Integrated Staging System. Lancet Neurol. 2022;21:632\u201344.","journal-title":"Lancet Neurol"},{"key":"1688_CR85","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1177\/1535370217750088","volume":"243","author":"RM Califf","year":"2018","unstructured":"Califf RM. Biomarker definitions and their applications. Exp Biol Med. 2018;243:213\u201321.","journal-title":"Exp Biol Med"}],"container-title":["European Journal of Human Genetics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41431-024-01688-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41431-024-01688-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41431-024-01688-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,20]],"date-time":"2024-11-20T02:05:09Z","timestamp":1732068309000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41431-024-01688-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9,24]]},"references-count":85,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2024,11]]}},"alternative-id":["1688"],"URL":"https:\/\/doi.org\/10.1038\/s41431-024-01688-7","relation":{},"ISSN":["1018-4813","1476-5438"],"issn-type":[{"value":"1018-4813","type":"print"},{"value":"1476-5438","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,9,24]]},"assertion":[{"value":"10 July 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 August 2024","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 August 2024","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 September 2024","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"As this study is a literature review, ethical approval was not required.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}